Rhumbline Advisers Cytosorbents Corp Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$2.37 - $3.65 $4,495 - $6,924	1,897 New	1,897 $6,000
Q2 2022 Aug 11, 2022	SELL	$1.76 - $3.22 $70,709 - $129,366	-40,176 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.88 - $4.23 $46 - $67	-16 Reduced 0.04%	40,176 $128,000
Q4 2021 Feb 10, 2022	SELL	$4.05 - $8.11 $2,673 - $5,352	-660 Reduced 1.62%	40,192 $168,000
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $2,975 - $4,126	425 Added 1.05%	40,852 $332,000
Q2 2021 Aug 05, 2021	SELL	$7.55 - $9.42 $16,089 - $20,074	-2,131 Reduced 5.01%	40,427 $305,000
Q1 2021 May 06, 2021	SELL	$8.23 - $11.48 $19,463 - $27,150	-2,365 Reduced 5.26%	42,558 $369,000
Q4 2020 Feb 10, 2021	BUY	$7.65 - $8.98 $36,352 - $42,672	4,752 Added 11.83%	44,923 $358,000
Q3 2020 Nov 12, 2020	SELL	$7.37 - $11.54 $29,774 - $46,621	-4,040 Reduced 9.14%	40,171 $320,000
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $34,395 - $58,001	5,477 Added 14.14%	44,211 $438,000
Q4 2019 Feb 05, 2020	BUY	$3.61 - $5.22 $747 - $1,080	207 Added 0.54%	38,734 $149,000
Q3 2019 Oct 23, 2019	SELL	$4.33 - $7.63 $1,299 - $2,289	-300 Reduced 0.77%	38,527 $194,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $22,271 - $29,268	-3,762 Reduced 8.83%	38,827 $257,000
Q1 2019 May 01, 2019	BUY	$6.82 - $8.56 $30,376 - $38,126	4,454 Added 11.68%	42,589 $322,000
Q4 2018 Jan 31, 2019	BUY	$7.05 - $12.64 $95,210 - $170,703	13,505 Added 54.83%	38,135 $308,000
Q3 2018 Nov 07, 2018	SELL	$10.95 - $14.8 $13,698 - $18,514	-1,251 Reduced 4.83%	24,630 $318,000
Q2 2018 Aug 06, 2018	BUY	$6.9 - $12.35 $178,578 - $319,630	25,881 New	25,881 $295,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.9M

Call Options Held

10.1K

Put Options Held

500

Avenir Corp Washington, DC

2.97M
Shares

$3.53 Million
0.21% of portfolio
Skylands Capital, LLC

2.84M
Shares

$3.38 Million
0.3% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.66M
Shares

$3.17 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$2.32 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.54M
Shares

$1.83 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account